Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Details)

v3.21.1
Income Tax (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
Income Tax (Details) [Line Items]  
Corporate tax rates 23.00%
Net carry forward tax losses $ 51,096
CollPlant Biotechnologies Ltd [Member]  
Income Tax (Details) [Line Items]  
Net carry forward tax losses $ 6,165